Assignee
SHANGHAI BENEMAE PHARMACEUTICAL CORP
CN·1 granted patent·6 pending applications·0 citations·filing 2016–2023
Top patents by PatentIndex Score
7 records- 0153US2023201311A1Compositions and methods for treating non-alcoholic steatohepatitis (nash)SHANGHAI BENEMAE PHARMACEUTICAL CORP·Filed 2022·Application pending·0 cites
- 0253US2023303690A1Novel anti-lag3 antibodies and methods of making and using the sameSHANGHAI BENEMAE PHARMACEUTICAL CORP·Filed 2023·Application pending·0 cites
- 0350US2023092769A1Combinational therapy comprising glp-1 and/or glp-1 analogs, and insulin and/or insulin analogsSHANGHAI BENEMAE PHARMACEUTICAL CORP·Filed 2022·Application pending·0 cites
- 0448US2023081034A1Dosing regimen of glp-1SHANGHAI BENEMAE PHARMACEUTICAL CORP·Filed 2022·Application pending·0 cites
- 0541US11958911B2Anti-coagulation factor XI antibodySHANGHAI BENEMAE PHARMACEUTICAL CORP·Filed 2019·Granted Apr 16, 2024·0 cites·15 claims
- 0636US2021052703A1Glp-1 composition for treating obesity and weight managementSHANGHAI BENEMAE PHARMACEUTICAL CORP·Filed 2020·Application pending·0 cites
- 0726US2016235855A1Stable aqueous parenteral pharmaceutical compositions of insulinotropic peptidesSHANGHAI BENEMAE PHARMACEUTICAL CORP·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SHANGHAI BENEMAE PHARMACEUTICAL CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →